References
- Traggiai E, Chicca L, Mazzucchelli L, Bronz L, Piffaretti JC, Lanzavecchia A, . Development of a human adaptive immune system in cord blood cell-transplanted mice. Science. 2004;304:104–7.
- Baenziger S, Tussiwand R, Schlaepfer E, Mazzucchelli L, Heikenwalder M, Kurrer MO, . Disseminated and sustained HIV infection in CD34+ cord blood cell-transplanted Rag2-/-gamma c-/- mice. Proc Natl Acad Sci USA. 2006;103: 15951–6.
- Watanabe S, Terashima K, Ohta S, Horibata S, Yajima M, Shiozawa Y, . Hematopoietic stem cell-engrafted NOD/SCID/IL2Rgamma null mice develop human lymphoid systems and induce long-lasting HIV-1 infection with specific humoral immune responses. Blood. 2007;109:212–8.
- Foss FM. Immunologic mechanisms of antitumor activity. Semin Oncol. 2002; (3 Suppl 7):5–11.
- Dudley ME, Rosenberg SA. Adoptive-cell-transfer therapy for the treatment of patients with cancer. Nat Rev Cancer. 2003; 3:666–75.
- Dreier T, Baeuerle PA, Fichtner I, Grün M, Schlereth B, Lorenczewski G, . T cell costimulus-independent and very efficacious inhibition of tumor growth in mice bearing subcutaneous or leukemic human B cell lymphoma xenografts by a CD19–/CD3– bispecific single-chain antibody construct. J Immunol. 2003;170:4397–402.
- Haas C, Krinner E, Brischwein K, Hoffmann P, Lutterbüse R, Schlereth B, . Mode of cytotoxic action of T cell-engaging BiTE antibody MT110. Immunobiology. 2009;214: 441–53.
- Kufer P, Lutterbüse R, Baeuerle PA. A revival of bispecific antibodies. Trends Biotechnol. 2004;22:238–44.
- Moldenhauer G, Momburg F, Möller P, Schwartz R, Hämmerling GJ. Epithelium-specific surface glycoprotein of Mr 34,000 is a widely distributed human carcinoma marker. Br J Cancer. 1987;56:714–21.
- Balzar M, Winter MJ, de Boer CJ, Litvinov SV. The biology of the 17-1A antigen (Ep-CAM). J Mol Med. 1999;77:699–712.
- Brischwein K, Schlereth B, Guller B, Steiger C, Wolf A, Lutterbuese R, . MT110: a novel bispecific single-chain antibody construct with high efficacy in eradicating established tumors. Mol Immunol. 2006;43:1129–43.
- Schlereth B, Fichtner I, Lorenczewski G, Kleindienst P, Brischwein K, da Silva A, . Eradication of tumors from a human colon cancer cell line and from ovarian cancer metastases in immunodeficient mice by a single-chain Ep-CAM-/CD3-bispecific antibody construct. Cancer Res. 2005;65: 2882–9.
- Becker M, Nitsche A, Neumann C, Aumann J, Junghahn I, Fichtner I. Sensitive PCR method for the detection and real-time quantification of human cells in xenotransplantation systems. Br J Cancer. 2002;87:1328–35.
- Kikuchi K, Kondo M. Developmental switch of mouse hematopoietic stem cells from fatal to adult type occurs in bone marrow after birth. PNAS. 2006;103:17852–7.
- Nitsche A, Junghahn I, Thulke S, Aumann J, Radonic A, Fichtner I, . Interleukin-3 promotes proliferation and differentiation of human hematopoietic stem cells but reduces their repopulation potential in NOD/SCID mice. Stem Cells. 2003; 21:236–44.
- Vanhecke D, Leclercq G, Plum J, Vandekerckhove B. Characterization of distinct stages during the differentiation of human CD69+CD3+ thymocytes and identification of thymic emigrants. J Immunol. 1995;155:1862–72.